TL;DR
Findings establish LIPA as a critical link between lipid metabolism, ferroptosis, and immune modulation in LUAD, and provide a prognostic signature for risk stratification as well as a candidate compound for targeting lipid metabolic vulnerabilities.
FKBP10 serves as a reliable prognostic biomarker and a promising therapeutic target for high-risk neuroblastoma and promotes aggressive NB progression by regulating stromal activation, ECM remodeling and malignant behaviors.
This study aimed to identify novel prognostic biomarkers for lung adenocarcinoma (LUAD) and elucidate their roles in tumor progression through the application of a multi-omics approach. Differentially expressed genes related to LUAD were identified using genome-wide and transcriptomics data, along with single-cell RNA...
PURPOSE The clinical management of gastric cancer is challenged by profound tumor heterogeneity and the emergence of drug-resistant cell populations. Ferroptosis, a regulated form of iron-dependent cell death driven by lipid peroxidation, has exhibited limited clinical efficacy as a monotherapy. Emerging evidence shows...
RNA sequencing of DRM-treated versus control rat C6 glioma cells identified 3747 differentially expressed genes, including 1660 upregulated and 2087 downregulated genes, with thrombospondin-1 markedly downregulated after DRM treatment, which may contribute to the anti-invasive effects of DRM.
Findings indicate that Olfactomedin-like 2B is required for HCC progression and represents a prognostic biomarker and potential therapeutic target.
The oncogenic ELFN1-AS1/LYPLA1 regulatory cascade is characterized as a potential biomarker and therapeutic target for precision management of osteosarcoma and establishes an LMRL-based for osteosarcoma prognostic stratification that reflects immune, genomic and therapeutic heterogeneity.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
